Clinical Trial Update: Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated eltrombopag for refractory Diamond-Blackfan anemia; results from the completed study were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diamond-blackfan Anemia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Anemia, Diamond-Blackfan | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-09-13